BLEPHAROSPASM

Clinical trials for BLEPHAROSPASM explained in plain language.

Never miss a new study

Get alerted when new BLEPHAROSPASM trials appear

Sign up with your email to follow new studies for BLEPHAROSPASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Completed 2

New injection offers hope for uncontrollable eye blinking

Symptom relief Not yet recruiting

This study tests a drug called DaxibotulinumtoxinA (DAXI) for adults with blepharospasm, a condition that causes uncontrollable blinking or eye muscle spasms. Twenty participants will receive DAXI injections for up to 12 months to see how long the effects last and how safe it is.…

Matched conditions: BLEPHAROSPASM

Phase: PHASE2 • Sponsor: University of Pennsylvania • Aim: Symptom relief

Last updated May 11, 2026 20:46 UTC

BLEPHAROSPASM

Get alerted when new BLEPHAROSPASM trials appear

New injection offers hope for uncontrollable eye blinking